In humans, hepatic PPARα levels negatively correlated with NASH, and an increase in PPARα expression levels was associated with histological improvement after lifestyle intervention or bariatric surgery [68]. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.